Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - November 2013

2nd Annual Cell Culture & Bioprocessing Congress 2013

04 Nov 2013 - 05 Nov 2013

Bookmark and Share

200 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

50 presentations, case studies and panel discussions focused on the key issues in cell line optimisation, process development and biological production

Oxford Global Conferences are proud to present our 2nd Annual Cell Culture & Bioprocessing Congress, taking place on 4th & 5th November, 2013 at the Copthorne Tara Hotel London Kensington.

This congress offers invaluable insights into key technological and scientific advances, addressing the most pressing challenges in the cell culture industry.

Over two days, the congress will attract over 200 senior-level decision makers working at the forefront of the cell culture and bioprocessing industry from the US and Europe. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates as well as ample networking opportunities, creating an interactive platform for high-level scientific and business discussion.

On Day One, our panel of cell culture experts will discuss the latest methods in cell line engineering and advances in cell culture development. Presentations will cover the critical issues in downstream processing, developing a successful cell fermentation process and achieving reliable process characterisation.

Day Two will feature case studies on the opportunities and challenges in 3D cell culture and cell media, and the latest insights into optimising cell line performance, quality and stability. Our internationally renowned speakers will also discuss quality by design, raw material management and single use technologies.

Co-located with the Stem Cell Congress, this event is a must attend for anyone working in cell culture and bioprocessing.

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos